Results 241 to 250 of about 1,772,484 (313)

Ebola Virus Update

Annals of Saudi Medicine, 1995
openaire   +3 more sources

Barriers to community engagement during the response to an Ebola virus disease outbreak in Uganda. [PDF]

BMJ Glob Health
Musoke D, Atusingwize E, Robins A, Nam S, Bonwitt J, Msukwa C, Rutayisire M, Upenytho G, Kyobe H, Mwebesa H.   +9 more
europepmc   +1 more source

Vesicular Release of Ebola Virus Matrix Protein VP40

, 2001
Joanna Timmins, Sandra Scianimanico, Guy Schoehn, Winfríed Weissenhorn   +3 more
openalex   +1 more source

Ophthalmic Sequelae of Ebola Virus Disease in Survivors, Sierra Leone. [PDF]

Emerg Infect Dis
Choo CH, Ward L, Crozier I, Fashina T, Yan D, Hayek BR, Hartley C, Vandy M, Mattia JG, Harrison-Williams L, Mustapha J, Drews-Botsch C, Yeh S, Shantha J.   +13 more
europepmc   +1 more source

Charting a novel path towards Ebola virus disease preparedness: Considerations for preventive vaccination. [PDF]

PLoS Med
Guttieres D, Diepvens C, Grais RF, Kiarie J, Vandaele N, Decouttere C.   +5 more
europepmc   +1 more source

Vaccine Potential of Ebola Virus VP24, VP30, VP35, and VP40 Proteins

, 2001
Julie A. Wilson, Mike Bray, Russell R. Bakken, Mary Kate Hart   +3 more
openalex   +1 more source

The Assembly of Ebola Virus Nucleocapsid Requires Virion-Associated Proteins 35 and 24 and Posttranslational Modification of Nucleoprotein [PDF]

, 2002
Yue Huang, Ling Xu, Yongnian Sun, Gary J. Nabel   +3 more
openalex   +1 more source

Reactive oxygen species-related oxidative changes are associated with splenic lymphocyte depletion in Ebola virus infection. [PDF]

Npj Imaging
Mani V, Chu WT, Yang HJ, Morris CP, Laux J, Byrum R, Cooper K, Liu DX, Wang H, Johnson C, Hadley K, Bernbaum JG, Hart R, Anthony SM, Marketon AE, Bernbaum-Cutler R, Pahar B, Worwa G, Kuhn JH, Crozier I, Calcagno C, Gale E.   +21 more
europepmc   +1 more source

Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein

, 2001
Ayato Takada, Shinji Watanabe, Katsunori Okazaki, Hiroshi Kida, Yoshihiro Kawaoka   +4 more
openalex   +1 more source

The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection. [PDF]

Sci Adv
Woolsey C, Cross RW, Chu VC, Prasad AN, Agans KN, Borisevich V, Deer DJ, Harrison MB, Martinez JK, Dobias NS, Fenton KA, Cihlar T, Nguyen AQ, Babusis D, Bannister R, Vermillion MS, Geisbert TW.   +16 more
europepmc   +1 more source